Amyris, Inc. (AMRS)
|52 Week Range||1.47-16.99|
|1y Target Est||-|
|DCF Unlevered||AMRS DCF ->|
|DCF Levered||AMRS LDCF ->|
|Debt / Equity||-666.06%||Strong Sell|
Upgrades & Downgrades
Latest AMRS news
3 Short Squeeze Penny Stocks To Watch Before Next Week
24 June 2022
Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Tech Stocks at the Top of Our Watchlists
24 June 2022
This basket of infrastructure software, technical instrument, and specialty chemicals stocks looks like a good value.
3 Stocks Wall Street Thinks Could Triple Your Money or Better
31 May 2022
Find out why the pros think these stocks could gain 200% or better.
AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022
23 May 2022
EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...
Better Buy: Gingko Bioworks vs. Amyris
22 May 2022
Which of these fallen stocks has the best chance of recovery?
Amyris: A Question Of Agency Costs
16 May 2022
Amyris' cash burn is currently high and their balance sheet weak, placing them in a vulnerable position as sentiment deteriorates. The business continues to expand rapidly, but margin improvements hav...
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
12 May 2022
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
Amyris: Elevated Cash Usage Causes Investors To Head For The Exits
11 May 2022
Discussing sell-off in the shares after the company's Q1 report revealed a much higher cash usage than anticipated by market participants. Even when assuming cash usage to trend down for the remainder...
Amyris, Inc. (AMRS) CEO John Melo on Q1 2022 Results - Earnings Call Transcript
10 May 2022
Amyris, Inc. (NASDAQ:AMRS ) Q1 2022 Results Conference Call May 10, 2022 9:00 AM ET Company Participants John Melo - President and Chief Executive Officer Han Kieftenbeld - Chief Financial Officer Con...